BCL2 and non-small cell lung carcinoma: As already mentioned in this paper, miR-503 modifies NSCLC cell resistance to CDDP by influencing expression of different target genes like Bcl-2, FANCA, PI3K p85, and IKK-β [55, 56, 101].